PhotoCure ASA (OSTO:PHOO) Net Change in Cash : kr34.3 Mil (TTM As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is PhotoCure ASA Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

PhotoCure ASA's Net Change in Cash for the three months ended in Dec. 2024 was kr2.8 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was kr34.3 Mil.

PhotoCure ASA Net Change in Cash Historical Data

The historical data trend for PhotoCure ASA's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Net Change in Cash Chart

PhotoCure ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

209.57

-11.99

-54.82

-8.57

34.35

PhotoCure ASA Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															4.45	-1.23	8.72	24.06	2.80

PhotoCure ASA Net Change in Cash Calculation

PhotoCure ASA's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	76.751	+	1.422	+	-43.822	+	0
	=	34.4

PhotoCure ASA's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 15.418 + -1.639 + -10.977 + 0

= 2.8

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr34.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhotoCure ASA Net Change in Cash Related Terms
Thank you for viewing the detailed overview of PhotoCure ASA's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

PhotoCure ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OSTO:PHOO) » Definitions » Net Change in Cash

Comparable Companies

OSL:VISTN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692 SZSE:000538 BOM:500087 ITCI VTRS TSE:4507 NBIX NSE:TORNTPHARM SHSE:688506 BOM:543904

Traded in Other Exchanges

PHCUF:USA PHO:Norway 0IMT:UK PHS:Germany

Address

Hoffsveien 4, Oslo, NOR, 0275

Website

https://www.photocure.com

PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, and the United States.

PhotoCure ASA Headlines

No Headlines